Principal Cybersecurity M&A Engineer
AbbVie
Summary
AbbVie is looking for a principal cybersecurity engineer with experience in mergers and acquisitions to join our Information Security Strategy and Intelligence group. AbbVie's Information Security group engages with our business development teams through several stages of a company relationship, whether it is a research-sharing relationship or an acquisition. We provide advisory services to reduce both risk and technical friction in these transactions.
Job description
As a Principal Cybersecurity Engineer, you will act as a single-point-of-contact between security and other technical and business teams, operating across both operational and strategic levels, developing and coordinating design and advisory responsibilities with different areas of the information security group on individual acquisitions and research ventures. You will interact with internal research and business intelligence teams, technical teams, and other members of the information security group to develop and deliver security products and services. You will play a key role in further shaping the services this program is delivering, while ensuring in-flight acquisitions have the right security services provided at the right times. This role will reside within the Cyber Threat Intelligence team, with a dotted-line relationship with our security architecture group.
Responsibilities
- Partner with infrastructure and technology teams, security teams, and acquisition target teams to coordinate core security and tech services during acquisition or divestiture.
- Partner with infrastructure, tech and security teams to develop, document, and deploy secure design patterns for collaborations with strategic alliance partners.
- Partner with internal security and technical teams to develop new security playbooks and services focused on business alliances and strategic acquisitions.
- SPOC for deals; broker/proxy for all ISRM services.
- Consult on behalf of ISRM between security and other technology and business teams, operating across both operational and strategic levels.
- Develop and coordinate design and advisory responsibilities with different areas of the information security group on individual acquisitions and divestitures.
- Interact with internal manufacturing operations and business intelligence teams, technical teams, and other members of the information security group to develop and deliver security products and services.
- Contribute to shaping and maturing the services this program is delivering, while ensuring in-flight engagements have the right security services provided at the right times.
- Consult on behalf of the AbbVie ISRM Security Architecture team on manufacturing acquisition and divestiture initiatives, providing operational and architectural leadership to ensure AbbVie OT Security standards are represented throughout design, planning, and execution of M&A engagements.
- Support Operational Technology (OT) Security aspects of AbbVie's Manufacturing and Research Technology initiatives by assisting in architecture, engineering, design, implementation, deployment, and operational transition of innovative & secure technology solutions.
- Lead OT cybersecurity, and secure by design assessments including detailed design reviews, network topology reviews, and mapping of data flows to ports, protocols, and services.
- Contribute to the creation of OT/ICS cybersecurity guardrails to ensure all OT architectures, solutions and technologies across the AbbVie enterprise are built using a secure-by-design methodology.
Qualifications
- Bachelor's Degree with 8 years of experience; Master's Degree with 7 years of experience
- Demonstrated creative 'out of the box' thinking to solve difficult technical problems and champion new technologies to achieve project goals
- Excellent written and oral English communication skills, as demonstrated by presenting at leading scientific or technical conferences
- Practical experience in a relevant discipline of cybersecurity (Cloud Security, AppSec, Network Security, Identity, Incident Response, etc.) and can speak to practical solutions
Preferred
- Experience with OT security is preferred
- Ideal candidates will have experience assessing cybersecurity risks, reviewing security architectures, and network segmentation
- Experience in incident response, cybersecurity risk management, and secure-by-design principles in operational environments is highly desirable
- Direct experience in a cybersecurity role, preferably as a Security Architect and/or roles supporting incident response operations
- Experience with designing and/or supporting solutions related to mergers, acquisitions, divestitures, and/or multi-company collaborations
- Experience with a variety of security tooling and capabilities, preferably with some hands-on/operational exposure (self-hosted and cloud)
- Working knowledge of popular cloud platforms and associated security solutions and collaboration platforms
- Working knowledge of Active Directory and related security constructs (domains, forests, trusts, etc.)
- Related technical/industry certifications (e.g., SANS, AWS, etc.)
Requirements
- Bachelor's Degree with 8 years of experience; Master's Degree with 7 years of experience
- Demonstrated creative 'out of the box' thinking to solve difficult technical problems and champion new technologies to achieve project goals
- Excellent written and oral English communication skills, as demonstrated by presenting at leading scientific or technical conferences
- Practical experience in a relevant discipline of cybersecurity (Cloud Security, AppSec, Network Security, Identity, Incident Response, etc.) and can speak to practical solutions
Benefits
- Paid time off
- Medical, Dental & Vision
- 401(k)
- Long-term incentive programs
Company overview
AbbVie is a global biopharmaceutical company that discovers, develops, and markets advanced therapies for some of the world's most complex and serious diseases. Founded in 2013 as a spin-off from Abbott Laboratories, AbbVie has established itself as a leader in immunology, oncology, neuroscience, eye care, and virology. The company's flagship product, Humira (adalimumab), was one of the world's top-selling drugs for treating autoimmune conditions like rheumatoid arthritis and Crohn's disease. AbbVie maintains a robust pipeline of innovative medicines and has expanded its portfolio through strategic acquisitions, including Allergan in 2020. With research facilities across the United States and globally, AbbVie focuses on advancing science to improve patient outcomes while maintaining strong commercial operations worldwide. The company operates with a patient-centric approach and invests significantly in research and development to address unmet medical needs across multiple therapeutic areas.